Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Curran

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancersStephanie Curran, Sinclair R Dundas, Jenny Buxton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Cytochrome p450 profile of colorectal cancer: identification of markers of prognosisMeera Kumarakulasingham, Patrick H Rooney, Sinclair R Dundas, et al.
The Journal of Pathology|October 12, 2004
The candidate oncogene ZNF217 is frequently amplified in colon cancerPatrick H Rooney, Attasit Boonsong, Morag C E McFadyen, et al.
The Journal of Pathology|March 29, 2002
Analysis of key cell-cycle checkpoint proteins in colorectal tumoursJudith A McKay, Joy J Douglas, Val G Ross, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancersStephanie Curran, Sinclair R Dundas, Jenny Buxton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Cytochrome p450 profile of colorectal cancer: identification of markers of prognosisMeera Kumarakulasingham, Patrick H Rooney, Sinclair R Dundas, et al.
The Journal of Pathology|October 12, 2004
The candidate oncogene ZNF217 is frequently amplified in colon cancerPatrick H Rooney, Attasit Boonsong, Morag C E McFadyen, et al.
The Journal of Pathology|March 29, 2002
Analysis of key cell-cycle checkpoint proteins in colorectal tumoursJudith A McKay, Joy J Douglas, Val G Ross, et al.
Pageof 2